Pulse Oximeters Explained: CPAP, Home Oxygen & Respiratory Devices (2026)
Physician-authored guide to pulse oximeters, CPAP, BiPAP, and home oxygen concentrators — with FDA accuracy notes, prescription requirements, and condition-specific guidance. By Dr. Rishav Das, M.B.B.S.
Medically reviewed by: Dr. Rishav Das, M.B.B.S. | ORCID: 0009-0007-2692-4542 |
Last reviewed: June 2026
Medically reviewed according to the medical standards outlined on our About page.
What This Guide Covers
A pulse oximeter measures your blood oxygen saturation (SpO₂) at home — but if your doctor has also mentioned CPAP, a home oxygen concentrator, or a nebulizer, this guide explains what each device does, who it’s prescribed for, and what the prescription process looks like. Every section is written and reviewed by a licensed physician.
Key Takeaways
- A fingertip pulse oximeter (OTC, no prescription needed) measures SpO₂ — normal range is 95–100% in healthy adults; readings below 90% warrant prompt medical evaluation.
- CPAP, BiPAP, and APAP machines treat obstructive sleep apnea (OSA) with positive airway pressure; all three require a prescription.
- Home oxygen concentrators generate oxygen from room air via pressure swing adsorption (PSA) and require both a prescription and a qualifying SpO₂ ≤88%.
- Nebulizers are available over the counter; the medications delivered through them require a prescription.
- Pulse oximeters may be less accurate in people with darker skin tones — a limitation documented in a 2020 NEJM study (Sjoding et al.) and addressed in subsequent FDA guidance.
⚠️ Educational content only. Nothing on this page constitutes medical advice, a diagnosis, or a treatment recommendation. Device selection, prescription, and use decisions must be made with a licensed healthcare provider. See our medical review standards →.
Jump to your situation:
- I was just told I have sleep apnea → CPAP, BiPAP & APAP Guide
- I manage asthma or COPD → Respiratory Treatment Devices
- My doctor mentioned supplemental oxygen → Oxygen Therapy Devices
- I want to track my oxygen at home → Pulse Oximeters
Who This Guide Is For: Recently Diagnosed Patients and Caregivers
This guide is written for adults recently diagnosed with a respiratory condition, caregivers helping a family member navigate equipment options, and anyone whose doctor has mentioned CPAP, supplemental oxygen, or a nebulizer — and who wants to understand what those devices actually do before their next appointment.
- What This Guide Covers
- Who This Guide Is For: Recently Diagnosed Patients and Caregivers
- Pulse Oximeters: How to Measure Blood Oxygen Saturation at Home
- Sleep Apnea Therapy Devices: CPAP, BiPAP, and APAP Explained
- Home Oxygen Therapy: Concentrators, Tanks, and How to Qualify
- Respiratory Treatment Devices: Nebulizers, Peak Flow Meters, and Spirometers
- How Pulse Oximeters, CPAP Machines, and Oxygen Concentrators Work
- Which Respiratory Device Is Right for Your Condition?
- When to Consult a Healthcare Provider or Go to the ER
- Insurance Coverage for Pulse Oximeters, CPAP, and Home Oxygen
- Frequently Asked Questions About Pulse Oximeters and Respiratory Devices
- Do I need a prescription for a pulse oximeter?
- What is the difference between CPAP and BiPAP?
- What SpO₂ level means I should see a doctor or go to the ER?
- Are pulse oximeters accurate for people with darker skin tones?
- What SpO₂ level qualifies for Medicare-covered home oxygen?
- What is APAP and how is it different from CPAP?
- References
Pulse Oximeters: How to Measure Blood Oxygen Saturation at Home
A pulse oximeter is a non-invasive device — most commonly a small clip worn on the fingertip — that measures blood oxygen saturation (SpO₂): the percentage of hemoglobin in your blood that is carrying oxygen. Normal SpO₂ in healthy adults is 95–100%. Standard fingertip pulse oximeters are available over the counter and do not require a prescription.
A pulse oximeter is a non-invasive device — most commonly a small clip worn on the fingertip — that measures blood oxygen saturation (SpO₂): the percentage of hemoglobin in your blood that is carrying oxygen. Normal SpO₂ in healthy adults is 95–100%; readings consistently below 95% at rest warrant consultation with a healthcare provider, and readings below 90% warrant prompt medical evaluation. [1, 2]
Standard fingertip pulse oximeters are available over the counter, do not require a prescription, and are the most practical tool for home oxygen monitoring in most situations.
The term pulse oximetry refers to the measurement process itself; the device performing it is the pulse oximeter.
→ For SpO₂ normal ranges by condition, see our SpO₂ metrics guide.
Fingertip vs Wrist vs Ring Pulse Oximeters: Which Is Right for You?

Pulse oximeters use photoplethysmography (PPG) — a light-based method that reads your pulse by shining light through your skin — to non-invasively estimate SpO₂ by measuring differential absorption of red and infrared light through perfused tissue. [3]
Device Format Comparison
| Feature | Fingertip Oximeter | Wrist-Worn Oximeter | Ring Oximeter |
| Sensor location | Fingertip | Wrist (via PPG) | Finger (ring form) |
| Continuous monitoring | No (spot check) | Yes | Yes |
| Intended use | Spot SpO₂ checks | Sleep/activity tracking | Overnight or activity monitoring |
| FDA clearance (typical) | Many have 510(k) clearance | Varies by model | Varies by model |
| Prescription required | No (OTC) | No (OTC) | No (OTC) |
| Clinical accuracy standard | ±2–3% ARMS | ±2–4% ARMS (varies) | ±2–4% ARMS (varies) |
| Common limitations | Motion artifact, nail polish, poor perfusion | Wrist positioning, motion | Ring fit, motion |
| Skin tone accuracy note | Performance may vary in darker skin tones [4] | Performance may vary [4] | Performance may vary [4] |
Key Limitations to Note
- SpO₂ readings may be inaccurate with cold extremities, poor peripheral circulation, nail polish, or acrylic nails. [3]
- Evidence suggests that pulse oximeters may overestimate SpO₂ in people with darker skin pigmentation — this is an area of active research and regulatory review. [4, 5]
- Wearable form factors are generally intended for general wellness tracking, not clinical monitoring, unless otherwise cleared by the FDA.
- Spot-check devices are not a substitute for continuous clinical monitoring in high-acuity settings.
SpO₂ vs SaO₂: What’s the difference?
SpO₂ (peripheral oxygen saturation) is what a pulse oximeter measures — an estimate of blood oxygen saturation based on light absorption through the skin. It is non-invasive and gives an approximate value.
SaO₂ (arterial oxygen saturation) is what an arterial blood gas (ABG) test measures — a direct measurement of oxygen in arterial blood drawn from the wrist or arm in a clinical setting. SaO₂ is considered more accurate and is used when clinical decisions require precise oxygen data.
If your medical records or clinic reports reference SaO₂ and your home device displays SpO₂, the values are closely related but not identical. Discuss the distinction with your provider if you are using your home oximeter to track a threshold set by your clinical team.
Pulse Oximeter Accuracy and Skin Tone: What the Evidence Shows
A 2020 study in the New England Journal of Medicine (Sjoding et al.) found that pulse oximeters were nearly three times more likely to miss occult hypoxemia — low arterialnoxygen not detected by the device — in Black patients compared to white patients. The FDA has since issued guidance on this limitation. Individuals with darker skin pigmentation whonare monitoring a respiratory condition should discuss this limitation with their healthcare provider.
Pulse oximeters may be less accurate in people with darker skin tones — a limitation with direct clinical implications for how results are interpreted.
A 2020 study published in the New England Journal of Medicine (Sjoding MW et al.) found that pulse oximeters were nearly three times more likely to miss occult hypoxemia — blood oxygen levels that are clinically low but not detected as such by the device — in Black patients compared to white patients. The analysis covered 10,789 patient measurements from multiple hospitals.
Pulse oximeters use two wavelengths of light (red and infrared) to estimate SpO₂ through the skin. Higher concentrations of melanin in darker skin pigmentation can affect light absorption in ways that cause the device to overestimate oxygen saturation — producing a falsely normal reading when actual oxygen levels may be below the clinical threshold for intervention.
The FDA classifies skin tone using the Fitzpatrick scale, a standardized six-level classification system. Consumer-grade wearables are not required to validate accuracy across Fitzpatrick categories; FDA-cleared medical-grade devices face more stringent accuracy and validation requirements. [4, 5]
What this means for you: If you have darker skin pigmentation and are using a pulse oximeter to monitor a respiratory condition, discuss this limitation with your healthcare provider. They may recommend clinical-grade monitoring, arterial blood gas (ABG) analysis, or a lower action threshold for your specific situation.
Medical-Grade vs Consumer Pulse Oximeters: Accuracy, FDA Clearance, and When It Matters
A meaningful distinction exists between FDA-cleared medical-grade pulse oximeters and consumer wellness devices.
Clinical vs Consumer Oximeter Comparison
| Attribute | Clinical / Medical-Grade | Consumer / Wellness |
| FDA pathway | 510(k) clearance (Class II medical device) | Often not FDA-cleared; may be Class I exempt |
| Accuracy standard | ±2% ARMS (FDA guidance: 70–100% SpO₂ range) | Variable; often ±2–4% or unspecified |
| Intended use | Diagnostic support; clinical monitoring | General wellness tracking |
| Data validation | Clinical trials across diverse skin tones required | Not required |
| Insurance coverage | May be covered with prescription | Generally not covered |
| Cost range | Higher ($50–$300+ for consumer-clinical; higher for hospital-grade) | Lower ($20–$80 typical) |
| Examples of use settings | Hospital, clinic, physician-supervised home monitoring | Personal health tracking, fitness, sleep apps |
⚠️ Regulatory Note: The FDA has issued guidance documents on pulse oximeter accuracy and limitations, particularly regarding performance in individuals with dark skin pigmentation. Readers should consult the FDA website or their healthcare provider for current guidance. [5]
Continuous SpO₂ Monitors: When a Fingertip Oximeter Isn’t Enough
A continuous SpO₂ monitor records blood oxygen saturation over an extended period — hours or overnight — rather than providing a single spot-check reading.
Continuous monitoring is most relevant when a physician needs to identify patterns such as nocturnal hypoxemia: episodes of low blood oxygen that occur during sleep and that a daytime fingertip check would miss entirely.
Nocturnal hypoxemia is clinically relevant in conditions including COPD, heart failure, obesity hypoventilation syndrome, and sleep-disordered breathing.
If your provider has ordered overnight oximetry, a continuous monitor (not a standard fingertip device) is typically required.
→ For how wearable SpO₂ tracking compares to clinical overnight oximetry, see our sleep tracker guide.
Continuous SpO₂ Monitor Characteristics
| Characteristic | Details |
| Signal type | Real-time PPG-based SpO₂ |
| Data output | Continuous numerical readout; trend recording |
| Alarm capability | Threshold-based alerts (e.g., SpO₂ <90%) |
| Primary clinical use | ICU, post-operative monitoring, sleep studies |
| Home-use applications | COPD monitoring, nocturnal hypoxemia assessment |
| Prescription status | May require prescription for medical-grade devices |
| Data connectivity | Bluetooth, cloud upload, EHR integration (clinical models) |
Considerations
- Clinical continuous monitors carry higher accuracy requirements than consumer wearables.
- Home continuous monitors may be used under physician guidance for conditions such as COPD, heart failure, or sleep-disordered breathing.
- Recording duration varies by device — relevant for overnight or extended monitoring protocols.
Sleep Apnea Therapy Devices: CPAP, BiPAP, and APAP Explained
Sleep apnea is a condition characterized by repeated partial or complete obstruction of the upper airway during sleep, resulting in disrupted breathing and intermittent hypoxemia. [6] Positive airway pressure (PAP) therapy is the most widely studied first-line treatment for moderate-to-severe obstructive sleep apnea (OSA). [7]
⚠️ All PAP therapy devices referenced in this section require a prescription in the United States. Device settings must be prescribed and configured by a licensed healthcare provider.

| Device Type | Primary Mechanism | Key Indication |
| CPAP | Fixed continuous pressure | Obstructive sleep apnea (OSA) |
| BiPAP/BPAP | Dual pressure (inhale/exhale) | OSA with high pressure needs; complex sleep apnea; some respiratory conditions |
| APAP/Auto-CPAP | Automatically adjusts pressure | OSA; varying pressure needs |
| Travel CPAP | Compact CPAP or APAP | OSA; travel and portability needs |
CPAP Machines: How They Work and What to Expect
Continuous positive airway pressure (CPAP) machines deliver a single, fixed pressure level throughout the breathing cycle. This constant airflow acts as a pneumatic splint, preventing airway collapse during sleep. [7]
CPAP Machine Key Features
| Feature | Details |
| Pressure delivery | Fixed, prescribed pressure (typically 4–20 cm H₂O) |
| Prescription required | Yes |
| Humidity support | Most include integrated or compatible heated humidifier |
| Data recording | Most current models record AHI, leak rate, usage hours |
| Connectivity | Many models offer Bluetooth/cellular data upload to provider |
| Mask compatibility | Full face, nasal, nasal pillow masks (sold separately) |
| Average daily use recommendation | ≥4 hours/night for insurance compliance (varies by plan) |
| Evidence base | Extensive; established first-line therapy for moderate-to-severe OSA [7] |
| Typical cost & coverage | Without insurance: $500–$1,500. Medicare Part B and most private insurers cover CPAP with a qualifying sleep study. Out-of-pocket cost with coverage: typically $0–$150 after deductible. Prior authorization is commonly required — confirm with your plan before ordering. |
What consistent CPAP use is associated with: Research shows that regular CPAP use in people with moderate-to-severe OSA is associated with reduced daytime sleepiness, improved mood and cognitive function, lower blood pressure, and a reduced risk of cardiovascular events. These outcomes depend on consistent nightly use — typically defined as 4 or more hours per night. [7, 8]
Common CPAP Concerns — and What Actually Helps
- Mask leak or discomfort is the most common reason people stop using CPAP — but it’s almost always fixable. Most DME suppliers offer mask exchanges within 30 days, and switching from a full-face mask to a nasal pillow mask resolves discomfort for many users. Ask your supplier about a trial period before committing to one style.
- Aerophagia (air swallowing) can cause bloating or discomfort. Lowering pressure or switching to APAP often helps — discuss this symptom with your prescribing provider rather than stopping therapy.
- Pressure-related discomfort at the fixed setting is common in the first weeks. Many providers now prescribe APAP for initial therapy because it adjusts automatically as your needs change.
- Claustrophobia with a full-face mask typically resolves with a nasal or nasal pillow mask alternative. Many people who initially struggle with CPAP adapt successfully after a mask change. [8]
Many CPAP users share mask-fitting tips and first-night experiences in online communities like Reddit’s r/SleepApnea. While peer advice can be reassuring, always confirm device or setting changes with your prescribing provider.
What Is AHI and Why It Determines Your CPAP Prescription
The Apnea-Hypopnea Index (AHI) measures the number of apnea and hypopnea events per hour of sleep. AHI severity: mild (5–14 events/hour), moderate (15–29 events/hour), severe (≥30 events/hour). AHI is the primary metric used to diagnose obstructive sleep apnea and to evaluate CPAP therapy effectiveness.
The Apnea-Hypopnea Index (AHI) measures the average number of breathing interruptions per hour of sleep. An apnea is a complete cessation of airflow lasting at least 10 seconds; a hypopnea is a partial reduction in airflow accompanied by either oxygen desaturation or an arousal from sleep.
AHI is the primary metric used to diagnose obstructive sleep apnea (OSA) and to assess whether CPAP therapy is working. AHI severity is classified as:
| AHI Range | Severity |
|---|---|
| < 5 events/hour | Normal (in adults) |
| 5–14 events/hour | Mild OSA |
| 15–29 events/hour | Moderate OSA |
| ≥ 30 events/hour | Severe OSA |
Most CPAP machines record nightly AHI data and transmit it to your provider via Bluetooth or cellular upload. A well-titrated CPAP should reduce residual AHI to below 5 events/hour. If your CPAP’s reported AHI remains elevated despite regular use, contact your prescribing provider — this may indicate mask leak, pressure adjustment need, or complex sleep apnea requiring adifferent device type.
CPAP vs BiPAP: When Bilevel Therapy Is Prescribed
Bilevel positive airway pressure (BiPAP/BPAP) devices deliver two distinct pressure levels: a higher inspiratory positive airway pressure (IPAP) and a lower expiratory positive airway pressure (EPAP). This differentiation may reduce the work of breathing on exhalation compared to fixed CPAP. [9]
BiPAP Key Specifications
| Attribute | Details |
| Pressure levels | IPAP (inspiration) and EPAP (expiration), set independently |
| Pressure range | Typically 4–25 cm H₂O (IPAP); lower EPAP |
| Prescription required | Yes |
| Primary indications | OSA with high pressure requirements; central sleep apnea; COPD with hypercapnia; neuromuscular conditions |
| Backup rate option | Some models include timed backup breath delivery (BiPAP-ST) |
| Cost comparison vs CPAP | Generally higher |
| Insurance coverage | May require documentation of CPAP trial failure or specific diagnosis |
When BiPAP May Be Considered
- Patient unable to tolerate CPAP exhalation pressure.
- Prescribing clinician determines CPAP insufficient for achieving adequate therapy.
- Presence of central or complex sleep apnea components.
- Specific comorbidities (e.g., COPD, OHS) where bilevel support is clinically indicated.
⚠️ BiPAP device selection and settings are determined exclusively by a prescribing clinician based on diagnostic data (e.g., polysomnography (an overnight sleep study that records breathing, oxygen levels, and brain activity results).
APAP Machines: How Auto-CPAP Works and Who It’s For
Auto-titrating PAP (APAP or AutoCPAP) machines automatically adjust delivered pressure within a prescribed range in response to detected breathing events, flow limitation, or snoring signals. [10]
APAP vs Fixed CPAP Comparison
| Attribute | Fixed CPAP | APAP |
| Pressure delivery | Single fixed level | Variable, within prescribed range |
| Algorithm response | None | Real-time adjustment to breathing events |
| Prescription required | Yes | Yes |
| Suitable for | Stable OSA with known pressure needs | Varying pressure needs; initial titration support |
| Data reporting | Usage, leak, AHI | Usage, leak, AHI, pressure distribution |
| Evidence base | Extensive | Well-established; comparable efficacy to CPAP in many OSA patients [10] |
| Common use case | Long-term OSA therapy | Post-titration therapy; variable severity OSA |
Travel CPAP: Maintaining Therapy on the Road
Travel CPAP devices are compact, lightweight versions of standard CPAP or APAP machines designed for portability. They are intended to maintain therapy continuity during travel.
Travel CPAP Characteristics
| Feature | Standard CPAP | Travel CPAP |
| Weight | ~1–3 lbs (450–1,360 g) | ~0.5–1 lb (225–450 g) typical |
| Size | Desktop unit | Compact; fits carry-on or small bag |
| Power input | AC (standard outlet) | AC + DC; many support 12V, USB-C, or battery packs |
| FAA carry-on status | Generally exempt from carry-on size limits as medical device | Same |
| Humidifier | Integrated heated humidifier standard | Often optional or waterless humidifier |
| Data recording | Standard | Varies; some models limited |
| Pressure range | Full range | Full range (device dependent) |
| Prescription required | Yes | Yes |
📝 Note: Travelers using PAP therapy should carry their prescription documentation and device power adapter information. Airlines generally classify CPAP devices as medical equipment exempt from standard carry-on restrictions, though policies vary. [11]
Home Oxygen Therapy: Concentrators, Tanks, and How to Qualify
Oxygen therapy devices deliver supplemental oxygen to individuals whose arterial oxygen levels fall below clinically acceptable thresholds. Supplemental oxygen is indicated for conditions including COPD with hypoxemia, pulmonary fibrosis, heart failure, and other conditions causing chronic hypoxemia. [12]
⚠️ Prescription Requirement: Supplemental oxygen is a prescription medical treatment in the United States. Use without medical supervision is not recommended and may be harmful in some clinical contexts. [12]
Home Oxygen Concentrators vs Portable Concentrators: Key Differences
Oxygen concentrators generate concentrated oxygen from ambient air by filtering out nitrogen using pressure swing adsorption (PSA) technology — a filtering process that pulls concentrated oxygen out of ordinary room air. They do not require oxygen tank refills. [13]
Home oxygen concentrators generate oxygen from room air through pressure swing adsorption (PSA) — a process that uses zeolite molecular sieves to selectively filter out nitrogen from ambient air, concentrating the remaining oxygen output to 87–96% purity at the prescribed flow rate. They do not require oxygen tank refills.
Home vs Portable Oxygen Concentrator Comparison
| Attribute | Home Oxygen Concentrator (HOC) | Portable Oxygen Concentrator (POC) |
| Oxygen delivery | Continuous flow | Continuous flow or pulse dose (device dependent) |
| Oxygen output | Typically 1–10 LPM | Typically 1–6 LPM (continuous); pulse dose settings vary |
| Power source | AC power only | AC, DC (car), and battery |
| Weight | 15–55 lbs (6.8–25 kg) | 2–10 lbs (0.9–4.5 kg) |
| Portability | Stationary; wheeled for in-home movement | Designed for travel and mobility |
| FAA approval | Not applicable | FAA-approved models available for air travel |
| Noise level | Moderate (30–55 dB typical) | Lower (varies) |
| Maintenance | Filter cleaning; regular service | Filter cleaning; battery maintenance |
| Prescription required | Yes | Yes |
| Typical cost & coverage | HOC: $500–$1,500 to purchase; often provided as rental by DME supplier. Medicare Part B covers home oxygen equipment (including concentrators) with a qualifying SpO₂ threshold and Certificate of Medical Necessity. Most private insurers follow similar criteria. [15] | POC: $1,500–$3,500. |
Pulse Dose vs Continuous Flow
| Delivery Mode | How It Works | Consideration |
| Continuous flow | Constant oxygen stream regardless of breath timing | Required for higher flow rates; sleep use; some clinical indications |
| Pulse dose (demand) | Oxygen delivered only on inhalation detection | More battery-efficient; may not be suitable for all patients or sleep use |
⚠️ Pulse dose delivery is not universally appropriate. Clinical guidance on whether continuous flow or pulse dose is suitable for a specific patient is determined by the prescribing provider. [13]
Oxygen Tanks vs Concentrators: Which Is Right for Your Situation?

Compressed gas oxygen tanks (cylinders) and liquid oxygen systems represent an alternative to concentrators for supplemental oxygen delivery.
Oxygen Tank vs Concentrator Comparison
| Attribute | Compressed Gas Tank | Liquid Oxygen System | Home Concentrator |
| Oxygen source | Pre-filled compressed gas | Liquid oxygen (cryogenic) | Generated from room air |
| Refill required | Yes (delivery service) | Yes (delivery service) | No |
| Flow capability | High flow possible | High flow possible | Limited by unit capacity |
| Portability | Small cylinders portable; large tanks stationary | Portable unit filled from reservoir | Stationary (HOC) or portable (POC) |
| Power dependency | None | None (reservoir) | Yes (electrical outlet or battery) |
| Power outage risk | Low (no power needed) | Low | High (concentrator stops) |
| Long-term cost | Higher (ongoing delivery) | Higher (ongoing delivery) | Lower (electricity only) |
| Storage safety | Requires secure, ventilated storage; fire risk | Requires secure, ventilated storage; cold burn risk | Minimal storage hazard |
| Prescription required | Yes | Yes | Yes |
⚠️ Safety Note: Compressed oxygen supports combustion. Users should follow all safety guidelines regarding storage near heat sources, smoking, and open flames. These guidelines are typically provided by the prescribing provider and oxygen supplier. [14]
How to Qualify for Supplemental Oxygen: Prescription Requirements and Medicare Criteria
Medicare Part B covers home oxygen equipment — including concentrators, tanks, and portable units — when SpO₂ is at or below 88% at rest, on exertion, or during sleep. Qualification also requires a Certificate of Medical Necessity (CMN) issued by the prescribing provider. Coverage is governed by CMS Local Coverage Determination L33797.
Supplemental oxygen is a prescription medical treatment in the United States — it cannot be self-prescribed or purchased for therapeutic use without a physician’s order.
A Certificate of Medical Necessity (CMN) is the specific document your physician must complete and submit to Medicare or your private insurer to authorize home oxygen equipment coverage. Without a valid CMN, oxygen equipment is typically not covered — regardless of clinical need.
Medicare’s criteria are governed by CMS Local Coverage Determination L33797, which requires SpO₂ at or below 88% at rest, on exertion, or during sleep. [15]
Prescription Process Overview
| Step | Details |
| 1. Clinical evaluation | Healthcare provider assesses symptoms and orders diagnostic testing |
| 2. Diagnostic testing | Arterial blood gas (ABG) or pulse oximetry under qualifying conditions |
| 3. Qualifying thresholds | SpO₂ ≤88% at rest, on exertion, or during sleep (Medicare criteria; clinical criteria may vary) [15] |
| 4. Prescription issuance | Provider issues Certificate of Medical Necessity (CMN) or equivalent |
| 5. Supplier sourcing | Durable medical equipment (DME) supplier provides device per prescription |
| 6. Insurance coverage | Medicare Part B and most insurers cover oxygen therapy with qualifying documentation [15] |
| 7. Follow-up | Provider re-evaluates oxygen need at intervals per clinical protocol |
⚠️ Prescribing thresholds and insurance coverage criteria vary. Readers should consult their healthcare provider and insurance plan for specific requirements.
→ Comparing home oxygen options? See our Best Oxygen Concentrators guide for product-level comparisons, or ask your DME supplier which models your insurer approves.
Respiratory Treatment Devices: Nebulizers, Peak Flow Meters, and Spirometers
Respiratory treatment devices support airway management, medication delivery, and lung function measurement. They are used across conditions including asthma, COPD, cystic fibrosis, and other pulmonary disorders.
Nebulizer Types: Jet, Ultrasonic, and Mesh Compared
Nebulizers convert liquid medication into a fine aerosol mist that can be inhaled directly into the airways and lungs. They are commonly used to deliver bronchodilators, corticosteroids, antibiotics, and mucolytics. [16]
Nebulizer Type Comparison
| Type | Mechanism | Key Characteristics | Common Use |
| Jet (pneumatic) nebulizer | Compressed air breaks liquid into aerosol | Reliable; lower cost; requires compressed air source | Home and clinical use; standard asthma/COPD |
| Ultrasonic nebulizer | High-frequency vibration atomizes liquid | Quieter; faster treatment; may heat medication | Home use; some medications incompatible |
| Mesh nebulizer | Liquid passes through vibrating mesh plate | Compact; battery-capable; efficient; portable | Travel; pediatric use; efficient medication delivery |
Nebulizer Use Considerations
| Consideration | Details |
| Prescription | Nebulizers are typically OTC devices; nebulized medications require prescription |
| Cleaning protocol | Regular disinfection required to prevent bacterial contamination [16] |
| Medication compatibility | Not all medications are compatible with all nebulizer types |
| Treatment time | Jet: 10–15 min; Ultrasonic: faster; Mesh: 5–10 min (varies) |
| Mask vs mouthpiece | Mouthpiece preferred for most adults; masks used for young children or those unable to use mouthpiece |
Peak Flow Meters for Asthma Management
A peak flow meter measures peak expiratory flow rate (PEFR) — the maximum speed at which a person can exhale after taking a full breath. PEFR is used primarily in asthma management to assess airway obstruction and monitor treatment response. [17]
Peak Flow Meter Summary
| Attribute | Details |
| Measurement | Peak expiratory flow rate (L/min) |
| Primary use | Asthma monitoring; response to bronchodilator therapy |
| Device types | Mechanical (standard); electronic (digital readout) |
| Prescription required | No (OTC) |
| Reference values | Compared to personal best or predicted normal values by age, sex, and height [17] |
| Frequency of use | As directed by prescribing provider; often daily in moderate-to-severe asthma |
| Zone system | Green (≥80% of personal best), Yellow (50–79%), Red (<50%) — zones defined by provider [17] |
| Limitations | Effort-dependent; results vary with technique and cooperation |
Spirometers: Clinical, Portable, and Incentive Types

A spirometer measures multiple lung function parameters, including forced vital capacity (FVC), forced expiratory volume in one second (FEV₁), and the FEV₁/FVC ratio — key values in diagnosing and staging obstructive and restrictive lung diseases. [18]
Spirometer Types and Context
| Type | Setting | Key Measurements | Use |
| Clinical spirometer | Physician office, pulmonary function lab | FVC, FEV₁, FEV₁/FVC, flow-volume loop, MVV | Diagnosis and staging of COPD, asthma, ILD |
| Handheld / portable spirometer | Home or point-of-care | FVC, FEV₁, FEV₁/FVC | Monitoring; telemedicine integration |
| Incentive spirometer | Post-operative/hospital | Sustained inspiratory volume | Respiratory muscle exercise; post-surgical lung expansion |
Spirometry Diagnostic Reference (GOLD COPD Staging)
Spirometry measures how much air you can breathe out and how fast. The key metric is the FEV₁/FVC ratio — the fraction of your total forced breath volume expelled in the first second. A ratio below 0.70 after bronchodilator use confirms airflow obstruction consistent with COPD. FEV₁ (forced expiratory volume in one second), expressed as a percentage of the predicted value for your age, sex, and height, then determines GOLD severity staging:
| GOLD Stage | FEV₁ % Predicted (post-bronchodilator, FEV₁/FVC <0.70) | Severity |
| GOLD 1 | ≥80% | Mild |
| GOLD 2 | 50–79% | Moderate |
| GOLD 3 | 30–49% | Severe |
| GOLD 4 | <30% | Very Severe |
Source: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2024 Report [19]
⚠️ Spirometry results must be interpreted by a qualified clinician in the context of clinical history, symptoms, and other diagnostic findings. The table above is for educational reference only.
How Pulse Oximeters, CPAP Machines, and Oxygen Concentrators Work
This section provides brief, mechanism-focused explanations of how each major device category functions. These descriptions are intended to support user understanding, not to substitute for clinical instruction.
Device Mechanism Summary Table
| Device | Core Technology | Measurement or Output |
| Fingertip pulse oximeter | Photoplethysmography (PPG): red/infrared light absorption ratio through fingertip | SpO₂ (%), pulse rate (bpm) |
| Wearable SpO₂ monitor | PPG sensor at wrist, ring, or earlobe; continuous signal processing | SpO₂ trends, heart rate, HRV |
| CPAP machine | Motor-driven blower generates fixed positive airway pressure via tubing and mask | Delivered pressure (cm H₂O); usage and AHI data |
| BiPAP/BPAP device | Dual-level pressure cycling: higher IPAP on inhalation, lower EPAP on exhalation | IPAP/EPAP pressures; usage data |
| APAP machine | Algorithm monitors airflow, detects events (apneas, hypopneas, flow limitation), adjusts pressure in real time | Pressure range; AHI; pressure distribution |
| Home oxygen concentrator | Pressure swing adsorption (PSA): nitrogen selectively removed from room air using zeolite molecular sieve | Oxygen-enriched output (typically 87–96% O₂ purity at prescribed LPM) |
| Portable oxygen concentrator | Same PSA principle as HOC; pulse dose or continuous flow; battery-powered option | SpO₂ support at prescribed LPM |
| Jet nebulizer | Compressed air entrains liquid medication; Bernoulli effect creates aerosol droplets | Aerosolized medication droplets (~1–5 µm for lung deposition) |
| Mesh nebulizer | Piezoelectric actuator vibrates mesh plate; liquid forced through mesh holes creates fine droplets | Small, consistent aerosol droplets; efficient medication delivery |
| Peak flow meter | Mechanical vane or electronic sensor measures maximum forced expiratory airflow | PEFR in liters per minute (L/min) |
| Spirometer | Measures volume and flow of air moved during controlled breathing maneuvers | FVC, FEV₁, FEV₁/FVC ratio, flow-volume loop |
Which Respiratory Device Is Right for Your Condition?
⚠️ The guidance in this section is educational and categorical. It does not constitute a recommendation for any individual. Device selection and prescription must be determined by a licensed healthcare provider based on a complete clinical evaluation.
Condition-Based Device Consideration Overview

| Condition | Primary Device Category | Monitoring Device | Notes |
| Obstructive sleep apnea | PAP therapy (CPAP, APAP, BiPAP) | Wearable SpO₂ (as directed) | Device type and settings prescribed after polysomnography (an overnight sleep study that records breathing, oxygen levels, and brain activity) |
| COPD | Oxygen concentrator (if hypoxemic); nebulizer; spirometer for monitoring | Continuous SpO₂ monitor or fingertip oximeter | Oxygen therapy requires qualifying SpO₂ thresholds |
| Asthma | Nebulizer; peak flow meter | Fingertip oximeter (acute monitoring) | Peak flow meters central to action plan management |
| General monitoring | Fingertip pulse oximeter | Same | Appropriate for periodic wellness checks; not diagnostic |
Devices for Sleep Apnea
| Consideration | Details |
| Diagnosis pathway | Sleep study (in-lab polysomnography or home sleep test) required for OSA diagnosis |
| First-line device | CPAP is the most widely studied first-line PAP therapy for moderate-to-severe OSA [7] |
| When APAP may be considered | When fixed pressure titration study is not completed; varying pressure needs |
| When BiPAP may be considered | High pressure requirements; CPAP intolerance; central or complex sleep apnea; specific comorbidities |
| Travel considerations | Travel CPAP maintains therapy continuity; same prescription applies |
| SpO₂ monitoring | May be used adjunctively to assess therapy effectiveness; not a substitute for PAP therapy |
| Mask selection | Full face, nasal, or nasal pillow; selected based on breathing pattern, comfort, and provider guidance |
📋 Free resource: [Questions to Ask Your Doctor Before Starting CPAP or Oxygen Therapy →] A printable checklist of 8 questions to bring to your next appointment — covering device options, prescription requirements, insurance coverage, and mask fitting. [Download the checklist — no sign-up required] (or) [Get it by email →]
Devices for COPD
| Consideration | Details |
| Oxygen therapy | Indicated when resting SpO₂ ≤88% or with qualifying exertional or nocturnal hypoxemia [15] |
| Concentrator type | Home concentrator for primary use; portable concentrator for mobility |
| Pulse dose vs continuous | Determined by prescribing provider based on SpO₂ response to each delivery mode |
| Nebulizer use | Commonly used to deliver bronchodilators (e.g., albuterol, ipratropium) and other inhaled medications [16] |
| Spirometry monitoring | Used periodically to assess disease progression and treatment response [18, 19] |
| SpO₂ monitoring | Ongoing monitoring at home may support early identification of exacerbations; guidance from provider recommended |
| BiPAP consideration | BiPAP may be prescribed for COPD with hypercapnic respiratory failure in specific clinical contexts [9] |
Devices for Asthma
| Consideration | Details |
| Peak flow meter | Central tool in asthma action plans; daily monitoring in moderate-to-severe asthma [17] |
| Nebulizer use | Delivers bronchodilators during acute episodes; used when MDI/spacer is insufficient or not tolerated [16] |
| Spirometry | Periodic spirometry supports diagnosis, classification, and monitoring of asthma control [18] |
| SpO₂ monitoring | Fingertip oximetry may be used during acute episodes to guide care-seeking decisions — thresholds defined by provider |
| CPAP/BiPAP | Not a standard asthma therapy; may be used in specific acute or comorbid scenarios under clinical direction |
Pulse Oximeters for General Health Monitoring
| Consideration | Details |
| Device type | Fingertip pulse oximeter (OTC) is appropriate for periodic SpO₂ spot checks |
| Accuracy considerations | Choose an FDA-cleared device; be aware of accuracy limitations in darker skin tones [4, 5] |
| Appropriate use | Wellness tracking; identifying significant changes in SpO₂ to prompt provider consultation |
| Not appropriate for | Diagnosing conditions; replacing clinical monitoring; managing active respiratory illness without provider guidance |
| When to consult a provider | SpO₂ readings consistently below 95%; rapid decline; symptoms of dyspnea, chest pain, or confusion |
When to Consult a Healthcare Provider or Go to the ER
SpO₂ below 90% warrants prompt medical evaluation. A sudden drop to below 80%, or any SpO₂ reading below 90% accompanied by symptoms such as chest pain, confusion, difficulty breathing, or blue discoloration of the lips or fingertips, may warrant emergency care — call 911 or go to the nearest emergency department.
The following situations warrant direct consultation with a licensed healthcare provider. This list is illustrative, not exhaustive.
| Situation | Recommended Action |
|---|---|
| SpO₂ consistently below 95% at rest | Consult provider promptly |
| SpO₂ below 90% | Seek prompt medical evaluation |
| SpO₂ below 80%, or below 90% with chest pain, confusion, difficulty breathing, or cyanosis | Emergency care — call 911 or go to ER |
| New or worsening shortness of breath | Consult provider |
| Suspicion of sleep apnea (witnessed apneas, excessive daytime sleepiness) | Seek referral for sleep evaluation |
| Considering supplemental oxygen without a prescription | Consult provider before use |
| COPD or asthma symptoms worsening despite current therapy | Consult provider |
| Uncertainty about which device is appropriate | Consult provider |
This page is produced under the medical review standards governing this site. Always follow your healthcare provider’s specific guidance for your personal SpO₂ thresholds.
This page is produced under the medical oversight standards described on our About page.
Insurance Coverage for Pulse Oximeters, CPAP, and Home Oxygen
Device costs vary widely, and insurance coverage is one of the most common reasons people delay or abandon treatment. The following outlines typical coverage criteria for the most commonly prescribed respiratory devices.
⚠️ Coverage criteria, authorization requirements, and out-of-pocket costs vary by plan, state, and individual clinical documentation. Always confirm with your insurance plan and prescribing provider before purchasing or renting a device.
CPAP / APAP / BiPAP Medicare Part B covers PAP therapy for OSA when prescribed following a qualifying sleep study (in-lab polysomnography or home sleep test) and when the patient demonstrates compliance — typically defined as use for ≥4 hours/night on ≥70% of nights during a 30-day period. Most private insurers apply similar criteria. Prior authorization is commonly required. Out-of-pocket costs with coverage are typically $0–$150 after deductible (20% of Medicare-approved amount). Devices may be rented or purchased depending on the supplier and plan.
Home Oxygen Therapy Medicare Part B (and most private insurers) cover home oxygen equipment — including concentrators, tanks, and portable units — when a qualifying SpO₂ threshold is met (typically ≤88% at rest, on exertion, or during sleep) and when a Certificate of Medical Necessity (CMN) is issued by the prescribing provider. Coverage is reviewed periodically; re-evaluation by your provider is required. [15]
Nebulizers The nebulizer device itself is typically covered under Medicare Part B as durable medical equipment when prescribed. Medications delivered via nebulizer require a separate prescription and may be covered under Medicare Part D or the equivalent prescription benefit under private plans.
Pulse Oximeters Standard OTC fingertip pulse oximeters are generally not covered by insurance. Medical-grade continuous monitoring devices prescribed for clinical monitoring may be covered under DME benefits with appropriate documentation.
Before your appointment, ask your provider:
- What are my out-of-pocket costs after insurance?
- Do I need prior authorization for this device?
- Will you issue a Certificate of Medical Necessity?
- Does my plan cover rental or purchase — and which is better for my situation?
Frequently Asked Questions About Pulse Oximeters and Respiratory Devices
Do I need a prescription for a pulse oximeter?
Standard fingertip pulse oximeters are available over the counter in the United States and do not require a prescription. They can be purchased at pharmacies, medical supply retailers, and online without a physician’s order.
Medical-grade continuous SpO₂ monitoring devices used in clinical or physician-supervised home monitoring settings may require a prescription, depending on the device classification and clinical context. For most adults monitoring SpO₂ at home — for general health tracking, post-COVID recovery, or known respiratory conditions — an OTC fingertip oximeter is typically sufficient. Confirm with your healthcare provider if you are unsure which device type is appropriate for your situation.
What is the difference between CPAP and BiPAP?
CPAP (continuous positive airway pressure) delivers a single, fixed pressure level throughout the entire breathing cycle — both during inhalation and exhalation. BiPAP (bilevel positive airway pressure) delivers two distinct pressure levels: a higher inspiratory positive airway pressure (IPAP) during inhalation and a lower expiratory positive airway pressure (EPAP) during exhalation.
BiPAP may be prescribed when a patient cannot tolerate CPAP exhalation pressure, when the prescribed pressure needs exceed the CPAP range, or when specific clinical conditions — including COPD with hypercapnia, central sleep apnea, or obesity hypoventilation syndrome — require bilevel pressure support. Both devices require a prescription. Device selection and pressure settings are determined by a prescribing clinician based on diagnostic data. →
What SpO₂ level means I should see a doctor or go to the ER?
SpO₂ readings consistently below 95% at rest warrant consultation with a healthcare provider. SpO₂ below 90% warrants prompt medical evaluation — do not wait for a scheduled appointment if your readings are persistently in this range.
A sudden drop to below 80%, or any SpO₂ reading below 90% accompanied by symptoms such as chest pain, confusion, difficulty breathing, or blue discoloration of the lips or fingertips, may warrant emergency care. In those situations, call 911 or go to the nearest emergency department.
Always follow your healthcare provider’s specific SpO₂ thresholds for your condition — individual clinical targets may differ from population-level guidelines.
Are pulse oximeters accurate for people with darker skin tones?
Pulse oximeters may overestimate blood oxygen saturation in people with darker skin tones — producing a falsely normal reading when actual oxygen levels may be below the threshold for clinical concern.
A 2020 study published in the New England Journal of Medicine (Sjoding MW et al.) found that pulse oximeters were nearly three times more likely to miss occult hypoxemia — dangerously low blood oxygen levels not detected by the device — in Black patients compared to white patients. The FDA has issued guidance on this limitation and continues to review standards for pulse oximeter validation across diverse skin tones. [4, 5]
If you have darker skin pigmentation and are using a pulse oximeter to monitor a respiratory condition, discuss this limitation with your healthcare provider. They may recommend a lower action threshold for your situation, clinical-grade monitoring, or arterial blood gas testing in place of oximetry for certain decisions.
What SpO₂ level qualifies for Medicare-covered home oxygen?
Medicare Part B covers home oxygen equipment — including concentrators, tanks, and portable units — when a qualifying SpO₂ threshold is documented: typically SpO₂ at or below 88% at rest, on exertion, or during sleep. Testing must be performed by or under the supervision of a licensed healthcare provider under qualifying conditions.
Qualification also requires a Certificate of Medical Necessity (CMN) — a specific document your physician must complete and submit to Medicare. Coverage criteria are governed by CMS Local Coverage Determination L33797. Private insurers generally follow similar criteria, though specific thresholds and documentation requirements vary by plan. [15]
Readers should confirm eligibility with their healthcare provider and insurance plan directly, as coverage determinations are made on an individual basis.
What is APAP and how is it different from CPAP?
APAP (auto-titrating positive airway pressure), also called AutoCPAP, automatically adjusts the delivered air pressure within a physician-prescribed range in real time. The device’s algorithm responds to detected breathing events — apneas, hypopneas, flow limitation, and snoring — and raises or lowers pressure accordingly, rather than delivering a single fixed level.
Standard CPAP delivers one fixed pressure throughout the night, regardless of what your breathing is doing at any given moment. APAP may be prescribed for patients with varying pressure needs, those in the initial titration phase, or those whose OSA severity changes with factors such as sleep position, REM sleep, alcohol use, or weight. Both CPAP and APAP require a prescription, and pressure settings must be configured by your prescribing provider.
References
- World Health Organization. Pulse Oximetry Training Manual. Geneva: WHO Press; 2011. Available at: https://www.who.int/patientsafety/safesurgery/pulse_oximetry/en/
- Jubran A. Pulse oximetry. Critical Care. 2015;19(1):272. doi:10.1186/s13054-015-0984-8
- Nitzan M, Romem A, Koppel R. Pulse oximetry: fundamentals and technology update. Medical Devices (Auckland, NZ). 2014;7:231–239. doi:10.2147/MDER.S47319
- Sjoding MW, Dickson RP, Iwashyna TJ, Gay SE, Valley TS. Racial bias in pulse oximetry measurement. New England Journal of Medicine. 2020;383(25):2477–2478. doi:10.1056/NEJMc2029240
- U.S. Food and Drug Administration. Pulse Oximeters: Recommendations for Patients and Caregivers. Updated 2024. Available at: https://www.fda.gov/medical-devices/safety-communications/pulse-oximeters-recommendations-patients-and-caregivers
- American Academy of Sleep Medicine. International Classification of Sleep Disorders. 3rd ed. (ICSD-3). Darien, IL: AASM; 2014.
- Epstein LJ, Kristo D, Strollo PJ, et al. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. Journal of Clinical Sleep Medicine. 2009;5(3):263–276.
- Weaver TE, Grunstein RR. Adherence to continuous positive airway pressure therapy: the challenge to effective treatment. Proceedings of the American Thoracic Society. 2008;5(2):173–178. doi:10.1513/pats.200708-119MG
- Masa JF, Mokhlesi B, Benítez I, et al. Long-term clinical effectiveness of continuous positive airway pressure therapy versus non-invasive ventilation therapy in patients with obesity hypoventilation syndrome: a multicentre, open-label, randomised controlled trial. The Lancet. 2019;393(10182):1721–1732. doi:10.1016/S0140-6736(18)32978-7
- Ayas NT, Patel SR, Malhotra A, et al. Auto-titrating versus standard continuous positive airway pressure for the treatment of obstructive sleep apnea: results of a meta-analysis. Sleep. 2004;27(2):249–253. doi:10.1093/sleep/27.2.249
- Federal Aviation Administration. Portable Oxygen Concentrators. Available at: https://www.faa.gov/passengers/fly_safe/portable_oxygen
- Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of COPD. 2024 Report. Available at: https://goldcopd.org
- Hardinge M, Annandale J, Bourne S, et al. British Thoracic Society guidelines for home oxygen use in adults. Thorax. 2015;70(Suppl 1):i1–i43. doi:10.1136/thoraxjnl-2015-206865
- National Fire Protection Association (NFPA). Home Oxygen Safety. Available at: https://www.nfpa.org
- Centers for Medicare & Medicaid Services. Local Coverage Determination (LCD): Home Oxygen (L33797). Available at: https://www.cms.gov
- Dolovich MB, Ahrens RC, Hess DR, et al. Device selection and outcomes of aerosol therapy: evidence-based guidelines. Chest. 2005;127(1):335–371. doi:10.1378/chest.127.1.335
- National Heart, Lung, and Blood Institute. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. NIH Publication No. 08-4051. Bethesda, MD: NHLBI; 2007.
- Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. European Respiratory Journal. 2005;26(2):319–338. doi:10.1183/09031936.05.00034805
- Global Initiative for Chronic Obstructive Lung Disease (GOLD). GOLD 2024 Pocket Guide to COPD Diagnosis, Management, and Prevention. Available at: https://goldcopd.org
Written by Dr. Rishav Das, M.B.B.S. — see About page for credentials
Reviewed according to the medical standards outlined on our About page
Last Updated: June, 2026
